Novartis (NVS) News Today $111.04 -2.04 (-1.80%) As of 03:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Novartis AG (NYSE:NVS) Shares Sold by Price T Rowe Associates Inc. MDPrice T Rowe Associates Inc. MD lowered its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 38.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 73,888 shares of the company's stock aMay 6 at 4:04 AM | marketbeat.comBioNTech Appoints Novartis Executive As Finance Chief, Reaffirms 2025 Outlook Focusing on Oncology ExpansionMay 5 at 3:49 PM | benzinga.comBioNTech says Novartis executive Zapata-Gomez to become CFOMay 5 at 6:34 AM | reuters.comNovartis AG (NYSE:NVS) Shares Sold by Mercer Global Advisors Inc. ADVMercer Global Advisors Inc. ADV lessened its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 1.6% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 145,759 shares of the company's stock after selling 2May 5 at 5:36 AM | marketbeat.comHutner Capital Management Inc. Purchases 3,324 Shares of Novartis AG (NYSE:NVS)Hutner Capital Management Inc. increased its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 129.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 5,894 shares of the company's stock after buying anMay 4 at 6:17 AM | marketbeat.comSchonfeld Strategic Advisors LLC Acquires Shares of 62,418 Novartis AG (NYSE:NVS)Schonfeld Strategic Advisors LLC bought a new position in Novartis AG (NYSE:NVS - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 62,418 shares of the company's stock, valued at approximately $6,0May 4 at 5:06 AM | marketbeat.comNovartis AG (NYSE:NVS) Shares Purchased by Lido Advisors LLCLido Advisors LLC increased its holdings in Novartis AG (NYSE:NVS - Free Report) by 39.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 16,178 shares of the company's stock after buying an additional 4,581May 4 at 5:05 AM | marketbeat.comNorthern Trust Corp Purchases 399,862 Shares of Novartis AG (NYSE:NVS)Northern Trust Corp raised its position in shares of Novartis AG (NYSE:NVS - Free Report) by 23.1% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,132,591 shares of the company's stock after purchasing an addiMay 4 at 4:57 AM | marketbeat.comVoya Investment Management LLC Sells 15,665 Shares of Novartis AG (NYSE:NVS)Voya Investment Management LLC lowered its holdings in Novartis AG (NYSE:NVS - Free Report) by 28.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 38,770 shares of the company's stock after selling 15,665May 4 at 4:19 AM | marketbeat.comNovartis AG (NOVN) Receives a Hold from Berenberg BankMay 3 at 11:19 PM | theglobeandmail.comAdvisorShares Investments LLC Acquires Shares of 4,360 Novartis AG (NYSE:NVS)AdvisorShares Investments LLC bought a new position in Novartis AG (NYSE:NVS - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The fund bought 4,360 shares of the company's stock, valued at approximately $424,000. Several other hedge funds have also recMay 2, 2025 | marketbeat.comBeacon Pointe Advisors LLC Sells 4,117 Shares of Novartis AG (NYSE:NVS)Beacon Pointe Advisors LLC trimmed its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 8.6% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 43,841 shares of the company's stock after selling 4,117 shares during the period. Beacon Pointe AdvisorsMay 2, 2025 | marketbeat.comNovartis to acquire San Diego-based Regulus in deal worth up to $1.7BMay 2, 2025 | msn.comRegulus CVR may be worth $3-$4 a share in Novartis deal - analystMay 2, 2025 | msn.comNovartis (NYSE:NVS) Posts Earnings Results, Beats Estimates By $0.16 EPSNovartis (NYSE:NVS - Get Free Report) announced its earnings results on Tuesday. The company reported $2.28 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.12 by $0.16. The company had revenue of $13.23 billion during the quarter, compared to analysts' expectations of $12.92 billion. Novartis had a net margin of 23.56% and a return on equity of 37.24%. The firm's quarterly revenue was up 11.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.80 earnings per share.May 1, 2025 | marketbeat.comNovartis (NYSE:NVS) Releases Earnings Results, Beats Estimates By $0.16 EPSNovartis (NYSE:NVS - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported $2.28 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.12 by $0.16. The company had revenue of $13.23 billion during the quarter, compared to the consensus estimate of $12.92 billion. Novartis had a return on equity of 37.24% and a net margin of 23.56%.May 1, 2025 | marketbeat.comNovartis to Buy Regulus Therapeutics for as Much as $1.7 BillionApril 30, 2025 | bloomberg.comNovartis to acquire Regulus for $7.00 a share in cashApril 30, 2025 | seekingalpha.comNovartis: Guidance 2025 Raised To Top End Of Prior Range - Buy ConfirmedApril 30, 2025 | seekingalpha.comAdakveo Market Epidemiology, Pipeline Analysis, Market Insights & Forecasts Report 2025, with Focus on NovartisApril 30, 2025 | globenewswire.comNovartis AG (NYSE:NVS) Q1 2025 Earnings Call TranscriptApril 30, 2025 | insidermonkey.comNovartis to Acquire Regulus in $1.7 Billion DealApril 30, 2025 | wsj.comNovartis to buy Regulus Therapeutics for up to $1.7 billionApril 30, 2025 | reuters.comEarnest Partners LLC Sells 13,236 Shares of Novartis AG (NYSE:NVS)Earnest Partners LLC trimmed its holdings in Novartis AG (NYSE:NVS - Free Report) by 1.6% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 795,911 shares of the company's stock after selling 13,236 shares during the quarter. Earnest Partners LLApril 30, 2025 | marketbeat.comKovitz Investment Group Partners LLC Buys 30,240 Shares of Novartis AG (NYSE:NVS)Kovitz Investment Group Partners LLC boosted its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 161.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 48,987 shares of the company's stock after aApril 30, 2025 | marketbeat.comNovartis AG (NVS) Q1 2025 Earnings Call Highlights: Impressive Growth and Strategic AdvancementsApril 30, 2025 | gurufocus.comNovartis Raises Forecast After Profit Beats EstimatesApril 29, 2025 | bloomberg.comSwiss drugmaker Novartis raises 2025 forecast after strong Q1 momentumApril 29, 2025 | msn.comNovartis AG (NVS) Q1 2025 Earnings Call TranscriptApril 29, 2025 | seekingalpha.comAquatic Capital Management LLC Buys 3,920 Shares of Novartis AG (NYSE:NVS)Aquatic Capital Management LLC increased its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 4.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 84,920 shares of the company's stock after acApril 29, 2025 | marketbeat.comNovartis posts better-than-expected first-quarter sales, raises full-year guidanceApril 29, 2025 | cnbc.comOneDigital Investment Advisors LLC Sells 3,177 Shares of Novartis AG (NYSE:NVS)OneDigital Investment Advisors LLC trimmed its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 31.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,972 shares of the company's stock after selling 3,1April 29, 2025 | marketbeat.comNovartis Lifts Guidance After Profit, Sales Top ViewsApril 29, 2025 | wsj.comNovartis more upbeat on 2025 guidance after strong Q1 momentumApril 29, 2025 | reuters.com4NVS : Earnings Preview For NovartisApril 28, 2025 | benzinga.com3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S. (NVS)See these three top-10 stocks in the pharmaceutical industry that are pledging investment in the United States totalling over $100 billion.April 28, 2025 | marketbeat.comRep. George Whitesides Sells Off Shares of Novartis AG (NYSE:NVS)Representative George Whitesides (D-California) recently sold shares of Novartis AG (NYSE:NVS). In a filing disclosed on April 23rd, the Representative disclosed that they had sold between $100,001 and $250,000 in Novartis stock on March 24th. The trade occurred in the Representative's "GEORGE WHITApril 28, 2025 | marketbeat.comNew Vernon Capital Holdings II LLC Sells 2,527 Shares of Novartis AG (NYSE:NVS)New Vernon Capital Holdings II LLC lowered its position in shares of Novartis AG (NYSE:NVS - Free Report) by 18.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,837 shares of the company's stock aApril 27, 2025 | marketbeat.comThree Seasons Wealth LLC Purchases New Stake in Novartis AG (NYSE:NVS)Three Seasons Wealth LLC bought a new stake in shares of Novartis AG (NYSE:NVS - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 3,400 shares of the company's stock, valued at approximately $331,000. Other hedge funds have alApril 27, 2025 | marketbeat.comStifel Financial Corp Boosts Stock Position in Novartis AG (NYSE:NVS)Stifel Financial Corp increased its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 1.1% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 221,396 shares of the company's stock after buying an additional 2,36April 27, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Shares Acquired by Tower Research Capital LLC TRCTower Research Capital LLC TRC increased its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 10,877.5% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 11,197 shares of the company's stock after purchasing an addApril 27, 2025 | marketbeat.comAnalysts Set Novartis AG (NYSE:NVS) Price Target at $123.38April 27, 2025 | americanbankingnews.comThese 2 Top Dividend Stocks Are Making Moves to Avoid the Impact of Tariffs: Are They Buys?April 26, 2025 | fool.comMGO One Seven LLC Increases Stock Position in Novartis AG (NYSE:NVS)MGO One Seven LLC boosted its holdings in Novartis AG (NYSE:NVS - Free Report) by 12.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,710 shares of the company's stock after buying an additional 3,042April 26, 2025 | marketbeat.comNovartis AG: Stable Outlook with Mixed Product Performance and Favorable Forex Impact Justifies Hold RatingApril 25, 2025 | tipranks.comMML Investors Services LLC Buys 19,331 Shares of Novartis AG (NYSE:NVS)MML Investors Services LLC raised its stake in Novartis AG (NYSE:NVS - Free Report) by 15.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 148,532 shares of the company's stock after acquiring an additional 19,33April 25, 2025 | marketbeat.comFirst Trust Advisors LP Grows Stock Holdings in Novartis AG (NYSE:NVS)First Trust Advisors LP increased its position in shares of Novartis AG (NYSE:NVS - Free Report) by 9.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 562,487 shares of the company'sApril 25, 2025 | marketbeat.comMarshall Wace LLP Makes New $8.63 Million Investment in Novartis AG (NYSE:NVS)Marshall Wace LLP acquired a new stake in shares of Novartis AG (NYSE:NVS - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 88,666 shares of the company's stock, valued at apApril 25, 2025 | marketbeat.comSIH Partners LLLP Acquires Shares of 25,400 Novartis AG (NYSE:NVS)SIH Partners LLLP acquired a new position in shares of Novartis AG (NYSE:NVS - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 25,400 shares of the company's stock, valued at approximately $2,472,000. A number of other institutional investorsApril 24, 2025 | marketbeat.comFayez Sarofim & Co Reduces Stock Holdings in Novartis AG (NYSE:NVS)Fayez Sarofim & Co decreased its position in Novartis AG (NYSE:NVS - Free Report) by 14.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 34,586 shares of the company's stock after selling 5,654 shareApril 24, 2025 | marketbeat.com Get Novartis News Delivered to You Automatically Sign up to receive the latest news and ratings for NVS and its competitors with MarketBeat's FREE daily newsletter. Email Address NVS Media Mentions By Week NVS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVS News Sentiment▼1.060.69▲Average Medical News Sentiment NVS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVS Articles This Week▼2915▲NVS Articles Average Week Get Novartis News Delivered to You Automatically Sign up to receive the latest news and ratings for NVS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NVO News AZN News SNY News GSK News TAK News ARGX News ONC News BNTX News SMMT News TEVA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVS) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novartis AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Novartis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NVS Stock Free NVS Stock Alerts